S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7129 +0.28%
PRE-MKT · 06:30 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
AC
INSIDER · 2 COMPANIES · 10% OWNER

ADAR1 Capital Management, LLC

Every open-market transaction filed under this name, Aug 20 to Oct 21. The same name appears at more than one issuer; filings don’t say whether it’s one person.

Filings
22
22 buys · 0 sells
Bought
$6.5M
open market, at cost
Sold
—
includes scheduled sales
Buys since
−0.6%
avg move from buy price, 22 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 21TENXTENAX THERAPEUTICS, INC.10% ownerBuy331,979$1.66$551K−1.7%
Oct 20TENXTENAX THERAPEUTICS, INC.10% ownerBuy254,342$1.60$406K+2.2%
Oct 19TENXTENAX THERAPEUTICS, INC.10% ownerBuy336,528$1.51$507K+8.2%
Oct 19INMInMed Pharmaceuticals Inc.10% ownerBuy1,086$1.32$1K+3.0%
Oct 15INMInMed Pharmaceuticals Inc.10% ownerBuy984$1.32$1K+2.9%
Oct 14INMInMed Pharmaceuticals Inc.10% ownerBuy8,021$1.33$11K+2.3%
Oct 8INMInMed Pharmaceuticals Inc.10% ownerBuy2,256$1.33$3K+2.4%
Oct 7INMInMed Pharmaceuticals Inc.10% ownerBuy3,046$1.33$4K+2.3%
Oct 6INMInMed Pharmaceuticals Inc.10% ownerBuy5,601$1.33$7K+2.4%
Oct 5INMInMed Pharmaceuticals Inc.10% ownerBuy18,182$1.33$24K+2.3%
Oct 2INMInMed Pharmaceuticals Inc.10% ownerBuy8,307$1.33$11K+2.3%
Oct 1INMInMed Pharmaceuticals Inc.10% ownerBuy16,431$1.33$22K+2.3%
Sep 16INMInMed Pharmaceuticals Inc.10% ownerBuy8,340$1.29$11K+5.5%
Sep 15INMInMed Pharmaceuticals Inc.10% ownerBuy54,256$1.30$70K+4.7%
Sep 14INMInMed Pharmaceuticals Inc.10% ownerBuy28,505$1.29$37K+5.1%
Sep 3TENXTENAX THERAPEUTICS, INC.10% ownerBuy900,000$1.78$1.6M−8.6%
Sep 2TENXTENAX THERAPEUTICS, INC.10% ownerBuy187,704$1.80$338K−9.4%
Sep 1TENXTENAX THERAPEUTICS, INC.10% ownerBuy179,058$1.80$322K−9.2%
Aug 31TENXTENAX THERAPEUTICS, INC.10% ownerBuy403,571$1.79$723K−9.0%
Aug 24TENXTENAX THERAPEUTICS, INC.10% ownerBuy107,374$1.75$188K−7.1%
Aug 21TENXTENAX THERAPEUTICS, INC.10% ownerBuy716,369$1.77$1.3M−7.8%
Aug 20TENXTENAX THERAPEUTICS, INC.10% ownerBuy202,124$1.78$360K−8.4%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.